Carregant...
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review
BACKGROUND: Convalescent plasma and hyperimmune immunoglobulin may reduce mortality in patients with viral respiratory diseases, and are being investigated as potential therapies for coronavirus disease 2019 (COVID‐19). A thorough understanding of the current body of evidence regarding benefits and...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2021
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8135693/ https://ncbi.nlm.nih.gov/pubmed/34013969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013600.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|